Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial.

Voso MT, de Botton S, Pfeilstöcker M, Alvarez AF, Wang K, See WL, Guerrero MU, de Menezes DL, Petrlik E, Prebet T, Roboz GJ

Open source

DOI
10.1111/bjh.70272
Published
2026 Feb
Container
British journal of haematology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70272,
  title = {Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial.},
  author = {Voso MT and de Botton S and Pfeilstöcker M and Alvarez AF and Wang K and See WL and Guerrero MU and de Menezes DL and Petrlik E and Prebet T and Roboz GJ},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70272},
  url = {https://doi.org/10.1111/bjh.70272}
}

RIS

TY  - JOUR
TI  - Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial.
AU  - Voso MT
AU  - de Botton S
AU  - Pfeilstöcker M
AU  - Alvarez AF
AU  - Wang K
AU  - See WL
AU  - Guerrero MU
AU  - de Menezes DL
AU  - Petrlik E
AU  - Prebet T
AU  - Roboz GJ
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70272
UR  - https://doi.org/10.1111/bjh.70272
ER  - 

APA

MT, V., S, D. B., M, P., AF, A., K, W., WL, S., MU, G., DL, D. M., E, P., T, P., & GJ, R. (2026). Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial.. British journal of haematology. https://doi.org/10.1111/bjh.70272

Source records